Pharma News

Glioblastomas (GBM) are tumors that arise from astrocytes—the star-shaped cells that make up the “glue-like,” or supportive tissue of the brain. These tumors are usually highly malignant (cancerous) because the cells reproduce quickly and they are supported by a large network of blood vessels  Approximately 10,000 patients diagnosed each year in the US and approximately 1,600 patients diagnosed each year in Japan.

In India Dental treatments are 65 to 90 per cent cheaper than the developed world. The favourable cost-benefit ratio, quality and technological infrastructure in treatment attracting international patients from US, Europe, Middle East and South East Asian region to India.

Diabetes is fast gaining the status of a potential epidemic in India with more than 62 million diabetic individuals currently diagnosed with the disease.India now carries 20 per cent of the global burden of diabetes.

To ensure medicines sold in the country are genuine products, the health ministry has developed a 'Track and Trace' mechanism which will enable consumers to check safety and authenticity of a drug through the internet. Barcode helps in tracking and tracing origin of drugs, which minimises the chances of genuine medicines being considered spurious, sub-standard or counterfeit. The Pharmaceutical  exporters keep demand in front of Union commerce ministry to exempt barcodes on mono cartons as a secondary level packaging on pharmaceuticals and drugs  export consignment  which is to be implemented from April 1, 2015 for tracing and tracking purposes.

Dr. Reddy’s Laboratories announced that it has entered into a definitive agreement to acquire a select portfolio of the established products business of UCB, in the territories of India, Nepal, Sri Lanka and Maldives. The acquired business is being sold on a slump sale basis. The transaction includes approximately 350 employees engaged in operations of the India Business. The revenues of the acquired business is approximately INR 150 Crores for calendar year 2014.

[adsense:336x280:8701650588]

The reappearance of tuberculosis and the rush of multidrug-resistant clinical isolates of Mycobacterium tuberculosis have reaffirmed tuberculosis as a key public health concern. Researchers from Global Homoeopathy Foundation (GHF) in collaboration with along with the Mumbai-based Haffkine Institute have developed a new homoeopathic drug for TB patients.

The Food and Drug Administration (FDA) is insisting the regulations in this regard are strictly followed. This ensures the products that come into the US are of the highest quality, have safety built into them and are effective. The US Food and Drug Administration (FDA) is increasing the frequency of inspections in India.